Featured Jobs
|
BPAS
|
|
Automotive Industries Trust Funds
|
|
Nova 401(k) Associates
|
|
Compass
|
|
The Pension Source
|
|
Mergers & Acquisition Specialist Compass
|
|
Pentegra
|
|
Strongpoint Partners
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans MM Daybright Financial
|
|
Relationship Manager for Defined Contributions KP Daybright Financial
|
|
Independent Retirement
|
|
BPAS
|
|
Retirement Plan Onboarding Specialist Compass
|
|
Attorney - ERISA, Benefits, & PRT Securian Financial Group
|
|
Combo Retirement Plan Administrator Strongpoint Partners
|
|
Senior Client Service Specialist EPIC RPS
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
New Testing Standards for Creditable Coverage Require Careful Review
Mercer 
[Guidance Overview] Sept. 28, 2025 "The 2026 changes to the Medicare Part D drug benefit passed under the Inflation Reduction Act are generally modest compared to the significant adjustments made in 2025. However, new instructions related to determining the creditable coverage status of prescription drug coverage allow plan sponsors to utilize a revised methodology for 2026. Plan sponsors should review the new methodology as they determine the most suitable one for their particular group health plan." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |